GlaxoSmithKline Says Cervarix Is Approved in Australia (Australia)
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline announced that Australian regulators have approved its Cervarix cervical cancer vaccine. The vaccine is still awaiting European regulatory approval. In the United States, GSK applied for marketing approval of the vaccine earlier this year and is hoping the Food and Drug Administration will grant it "priority review" status, which would speed the marketing and approval of the vaccine in the United States. (Click here for more - May Require Paid Subscription